Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Pharma
GLP-1s still unavailable in lower-income countries: MSF
Médecins Sans Frontières urged GLP-1 drug makers to "relinquish their stranglehold" on the meds and license them to generics makers to boost access.
Zoey Becker
Mar 28, 2024 8:00am
Novo Nordisk, Actylis ink pact to supply antiseptic in Europe
Mar 25, 2024 10:15am
EU regulator signs off on Novo's weekly insulin and other meds
Mar 22, 2024 11:39am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
Catalent conducting fresh round of layoffs in Indiana
Mar 21, 2024 12:27pm
Novo Nordisk lays out $560M to boost drug production in China
Mar 19, 2024 11:51am